High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL

Kevin J. Curran; Steven Margossian; Nancy A. Kernan; Lewis B. Silverman; Jae H. Park; Craig S. Sauter; Eric L. Smith; Farid Boulad; Maria Cancio; Christopher J. Forlenza

doi:10.1182/blood.v130.suppl_1.1326.1326

High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL

Identifier:nobleid.org/w1/20260515/EB32A028

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB32A028.svg?ark=w1%2F20260515%2FEB32A028)](https://nobleid.org/work/w1/20260515/EB32A028)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Christopher J. Forlenza

Claim authorship of this work

High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL

Identifier:nobleid.org/w1/20260515/EB32A028

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB32A028.svg?ark=w1%2F20260515%2FEB32A028)](https://nobleid.org/work/w1/20260515/EB32A028)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Christopher J. Forlenza

Claim authorship of this work